Pulse Biosciences (PLSE) Other Operating Expenses (2015 - 2025)

Pulse Biosciences' Other Operating Expenses history runs 9 years deep, the most recent figure standing at $279000.0 for Q3 2025.

• On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $279000.0 in Q3 2025; TTM through Dec 2025 was $279000.0, a N/A change from a year earlier, with the FY2022 full-year figure at $24.0 million, up 43.33% from the prior year.
• Other Operating Expenses slipped to $279000.0 in Q3 2025 per PLSE's latest filing, from $2.1 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $10.4 million in Q3 2022 and bottomed at $279000.0 in Q3 2025.
• The 3-year median for Other Operating Expenses is $4.1 million (2021), against an average of $4.6 million.
• Biggest YoY gain for Other Operating Expenses was 152.24% in 2022; the steepest drop was 61.11% in 2022.
• Year by year, Other Operating Expenses stood at $5.3 million in 2021, then sank by 61.11% to $2.1 million in 2022, then sank by 86.45% to $279000.0 in 2025.
• Per Business Quant, the three latest PLSE Other Operating Expenses figures stand at $279000.0 (Q3 2025), $2.1 million (Q4 2022), and $10.4 million (Q3 2022).